You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

lirilumab

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumors Trial in United States (Epacadostat, Nivolumab, Ipilimumab)

Terminated
Has Results
  • Solid Tumors
  • Birmingham, Alabama
  • +4 more
Feb 24, 2022

CANCER,NOS Trial in Worldwide (Lirilumab, Nivolumab, Ipilimumab)

Completed
  • CANCER,NOS
  • Lirilumab
  • +2 more
  • San Francisco, California
  • +29 more
Dec 10, 2020

Leukemia, Chronic Lymphocytic Leukemia, Lymphocytic Leukemia Trial in Houston (Lirilumab, Rituximab)

Completed
Has Results
  • Leukemia
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 26, 2020

Leukemia Trial in Houston (Lirilumab, Nivolumab, Azacitidine)

Terminated
Has Results
  • Leukemia
  • Lirilumab
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 6, 2020

Children, Adolescents and Young Adults With Refractory or Recurrent Malignancies Trial in Worldwide (Ribociclib, Topotecan,

Unknown status
  • Children, Adolescents and Young Adults With Refractory or Recurrent Malignancies
  • Copenhagen, Denmark
  • +6 more
Feb 23, 2021

Acute Biphenotypic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid

Terminated
Has Results
  • Acute Biphenotypic Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 5, 2019

Multiple Myeloma Trial in Spain, United States (Elotuzumab, Lirilumab, Urelumab)

Completed
  • Multiple Myeloma
  • Little Rock, Arkansas
  • +6 more
Oct 30, 2017

CANCER, NOS Trial in United States (Lirilumab, Ipilimumab)

Completed
  • CANCER, NOS
  • Tampa, Florida
  • +5 more
Jul 20, 2015